IQVIA™ Real-World Insights Bibliography

Empagliflozin is Associated with Lower Risk of Cardiovascular Events and All-Cause Mortality in Routine Care in East Asia: Results from the EMPRISE Study
Author(s): Dae Jung Kim (1), Wayne H-H Sheu (2), Wook-Jin Chung (3), Daisuke Yabe (4-7), Kyoung Hwa Ha (1), Masaomi Nangaku (8), Elise Chia-Hui Tan (9), Koichi Node (10), Atsutaka Yasui (11), Weiyu Lei (12), Sunwoo Lee (13), Laura Saarelainen (14), Anouk Deruaz-Luyet (15), Moe H. Kyaw (16) and Yutaka Seino (4,17), EMPRISE East Asia Study Group
Affiliations(s): "1 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 2 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 3 Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea 4 Kansai Electric Power Medical Research Institute, Kobe, Japan 5 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 6 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 7 Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan 8 Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan 9 National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan, and Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan 10 Department of Cardiovascular Medicine, Saga University, Saga, Japan 11 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan 12 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan 13 Boehringer Ingelheim Korea Ltd, Seoul, Korea 14 IQVIA, Espoo, Finland 15 Boehringer Ingelheim International GmbH, Ingelheim, Germany 16 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA 17 Kansai Electric Power Hospital, Osaka, Japan "
Publication(s):  "JDI journal Virtual Conference: ACC, May 2021"
Document Type(s): Article,
Countries: Japan, Korea, Taiwan,
Click here for the abstract
C:
Y:
Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study,
2023
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, Retrospective cohort analysis,
  Add to report
 
 
Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons
Author(s): Taisuke Ito 1, Kazumasa Kamei 2, Akira Yuasa 3, Fumihiro Matsumoto 2, Yayoi Hoshi 4, Masafumi Okada 4, Shinichi Noto 5 (rwesheorj 4)
Affiliations(s): 1) Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan 2) Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan 3) Health and Value, Pfizer Japan Inc., Tokyo, Japan 4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  The Journal of Dermatology
Document Type(s): Online article,
Countries: Japan,
Click here for the abstract
C:
Y:
Dermatology, Mental health,
2022
  L:
A:
English
Patient questionnaire, Quality of life, Survey research,
  Add to report
 
 
Physician awareness and understanding of hereditary angioedema: A web-based study in Japan
Author(s): Atsushi Fukunaga MD, PhD1,2| Miwa Kishimoto MD, PhD3| Akinori Oh PhD3|Takeshi Akiyama MBA4| Ippei Kotera PhD3| Yoichi Inoue MD, JD3| Junichi Maehara MD5
Affiliations(s): 1Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan2Division of Medicine for Function and Morphology of Sensory Organs, Department of Dermatology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan4Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan5Department of Acute Care and General Medicine, Emergency and Critical Care Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan
Publication(s):  Journal of Cutaneous Immunology and Allergy.
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Rare disease,
2022
  L:
A:
English
Survey research,
  Add to report
 
 
Cost-Effectiveness of Vonoprazan Compared With Proton Pump Inhibitors in Patients Taking Low-Dose Aspirin for Secondary Prevention of Cardiovascular Events in Japan
Author(s): Masanobu Ishii, Takashi Kawai, Kenichi Tsujita, Ataru Igarashi, Manabu Suzuki, Hisato Deguchi, Jovelle Fernandez
Affiliations(s): Masanobu Ishii Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University [Japan] Takashi Kawai Department of Gastroenterological Endoscopy, Tokyo Medical University [Japan] Kenichi Tsujita Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University [Japan] Ataru Igarashi Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo [Japan] Manabu Suzuki Japan Medical Office, Takeda Pharmaceutical Company Limited [Japan] Hisato Deguchi Japan Medical Office, Takeda Pharmaceutical Company Limited [Japan] Jovelle Fernandez Japan Medical Office, Takeda Pharmaceutical Company Limited [Japan]
Publication(s):  Circulation Journal
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Cardiovascular disease,
2022
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Development of a clinical prediction model for recurrence and mortality outcomes after Clostridioides difficile infection using a machine learning approach
Author(s): Daniel Ruzicka 1, Takayuki Kondo 1, Go Fujimoto 1, Andrew P.Craig 2, Seok-Won Kim 2, Hiroshige Mikamo 3
Affiliations(s): 1) Medical Affairs, MSD K.K., Tokyo, Japan, Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, 102-8667, Japan 2) Real World Evidence Solutions, IQVIA Solutions Japan K.K., Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan 3) Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, 1-1, Yazakokarimata, Nagakute, Aichi, 480-1195, Japan
Publication(s):  Anaerobe
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Infectious disease,
2022
  L:
A:
English
Methodology,
  Add to report
 
 
Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan
Author(s): Masaki Shiota 1,Raf De Moor 2,Yosuke Koroki 2,Dae Young Yu 3,David Bin-Chia Wu 4
Affiliations(s): 1) Department of Urology, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan 2) Integrated Market Access, Janssen Pharmaceutical KK, Tokyo, Japan 3) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore 4) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore;e Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore;f School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia
Publication(s):  Current Medical Research and Opinion
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Oncology,
2022
  L:
A:
English
Database Study,
  Add to report
 
 
Budget impact analysis of Jivi® (damoctocog alfa pegol, BAY 94-9027) in severe Hemophilia A in Japan
Author(s): Teruhisa Fujii 1, Yuko Kidoguchi 2, Noriko Takahashi 2, Eric Yu 3, Dilinuer Ainiwaer 3, Aidan Byrne 4 (rwesheorj 3)
Affiliations(s): 1) Division of Blood Transfusion, Hiroshima University Hospital, Hiroshima, Japan 2) Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan 4) IQVIA UK, London, UK
Publication(s):  Journal of Medical Economics
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Health economics,
2021
  L:
A:
English
Budget impact,
  Add to report
 
 
Real-world treatment and health care resource use among severe asthma patients in Japan
Author(s): Yasuo To 1, Yurie Taguchi 2, Tatsuya Shimazaki 2, Kazuhiko Arima 2, Eric Yu 3, Sven Demiya 3, Takashi Iwanaga 4 (rwesheorj 3)
Affiliations(s): 1) Department of Pulmonary Medicine, International University of Health and Welfare, School of Medicine, 1-4-3 Mita, Minato-ku, Tokyo 108-8329, Japan 2) Sanofi K.K., 3-20-2 Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan 3) IQVIA Solutions Japan K.K., Keikyu Dai-7 Building 4-10-8, Takanawa Minato-ku, Tokyo 108-0074, Japan 4) Kindai University, 377-2 Ohno Higashi, Osakasayama City, Osaka 589-8511, Japan
Publication(s):  Respiratory Investigation
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Clinical practice,
2021
  L:
A:
English
Database Study,
  Add to report
 
 
Cost-effectiveness analysis of the treatment strategies with or without opioid medications in surgery-eligible patients with osteoarthritis in Japan
Author(s): Tomoyuki Takura 1, Akira Yuasa 2, Naohiro Yonemoto 2, Sven Demiya 3, Hiroyuki Matsuda 3, Nozomi Ebata 4, Koichi Fujii 4, Muneaki Ishijima 5 (rwesheorj 3)
Affiliations(s): 1) Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 2) Health and Value, Pfizer Japan Inc., Shinjuku Bunka Quint Building, 3-22-7, Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan 4) Medical Affairs, Pfizer Japan Inc, Tokyo, Japan 5) Department of Medicine for Orthopaedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo, Japan
Publication(s):  PharmacoEconomics - Open
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Health economics,
2021
  L:
A:
English
Cost effectiveness, Literature Review,
  Add to report
 
 
Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study
Author(s): Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Dilinuer Ainiwaer 2 (rwesheorj 2)
Affiliations(s): 1) MSD K.K, Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  Current Medical Research and Opinion
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Infectious disease,
2021
  L:
A:
English
Database Study,
  Add to report
 
 
 1 of 6 Next Page Last Page